Of these, CD206+, CD204+ and CD163+ Mφs are suggested to represent immunosuppressive Mφs that promote tumor progression, whereas CD169+ Mφs display antitumor properties in HCC (18–20). The gene discussed is SIGLEC1; the disease is neoplasm.